ArticleJournal of translational medicine2023

Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay.

Xueying Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.